Screening Asymptomatic Subjects for Subclinical Atherosclerosis. Not So Obvious

Journal of the American College of Cardiology

Volumn 56, Issue 2, 2010, Pages 106-108

  Lauer, Michael S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

atherosclerosis; imaging; prevention; screening

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN;

ADVERTIZING; ATHEROSCLEROSIS; CANCER DIAGNOSIS; CANCER INCIDENCE; CORONARY ARTERY DISEASE; HIGH RISK PATIENT; MEDICAL RESEARCH; MEDICAL SOCIETY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SCREENING;

ADULT; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMANS;

EID: 77953905274     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.059     Document Type: Review

References (22)

1. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 350 (2004) 2239-2246
2. Andriole G.L., Crawford E.D., Grubb III R.L., et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360 (2009) 1310-1319
3. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
4. Esserman L., Shieh Y., and Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 302 (2009) 1685-1692
5. Woods W.G., Gao R.N., Shuster J.J., et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 346 (2002) 1041-1046
6. Welch H.G., Woloshin S., and Schwartz L.M. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 331 (2005) 481
7. Young L.H., Wackers F.J., Chyun D.A., et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301 (2009) 1547-1555
8. Patz Jr. E.F., Goodman P.C., and Bepler G. Screening for lung cancer. N Engl J Med 343 (2000) 1627-1633
9. Detrano R., Guerci A.D., Carr J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358 (2008) 1336-1345
10. O'Malley P.G. A double take on serial measurement of coronary artery calcification. Arch Intern Med 169 (2009) 2051-2052
11. Guide to Clinical Preventive Services. 2nd edition (2009), United States Preventive Services Task Force, Washington, DC
12. Bonow R.O. Clinical practice. Should coronary calcium screening be used in cardiovascular prevention strategies?. N Engl J Med 361 (2009) 990-997
13. Lord S.J., Irwig L., and Simes R.J. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?. Ann Intern Med 144 (2006) 850-855
14. Nelson H.D., Tyne K., Naik A., Bougatsos C., Chan B.K., and Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151 (2009) 727-737 W237-42
15. Ashton H.A., Buxton M.J., Day N.E., et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 360 (2002) 1531-1539
16. National Lung Screening Trial. (NCT00047385) [trial description]. http://www.clinicaltrials.gov/ct2/show/NCT00047835 Accessed May 18, 2010
17. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207
18. Shah P.K. Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we?. J Am Coll Cardiol 56 (2010) 98-105
19. Lauer M.S. Discarding logic: 2008 Ancel Keys memorial lecture. Circulation 119 (2009) 1533-1537
20. Lauer M.S. Screening for coronary heart disease: has the time for universal imaging arrived?. Cleve Clin J Med 74 (2007) 645-650 653-4, 656
21. Lee T.H., and Brennan T.A. Direct-to-consumer marketing of high-technology screening tests. N Engl J Med 346 (2002) 529-531
22. Hingorani A.D., and Psaty B.M. Primary prevention of cardiovascular disease: time to get more or less personal?. JAMA 302 (2009) 2144-2145